{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:50:19Z","timestamp":1754164219463,"version":"3.41.2"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Vulvar melanoma is a rare malignancy with frequent recurrence and poor prognosis. National guidelines recommend wide local excision of these tumors with allowances for narrower margins for anatomic and functional limitations, which are common on specialty sites. There is presently a lack of data of margin positivity after standard excision of vulvar melanomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>We aim to evaluate the rate of positive margins after standard excision of vulvar melanomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Retrospective cohort study of surgically excised vulvar melanomas from the NCDB diagnosed from 2004 to 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>We identified a total of 2,226 cases. Across surgical approaches and tumor stages, 17.2% (Standard Error [SE]: 0.8%) of cases had positive surgical margins. Among tumor stages, T4 tumors were most commonly excised with positive margins (22.9%, SE: 1.5%). On multivariable survival analysis, excision with positive margins was associated with significantly poorer survival (Hazard Ratio 1.299, <jats:italic toggle=\"yes\">p<\/jats:italic> = .015).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>We find that positive margin rates after standard excision of vulvar malignancies are higher than for other specialty site melanomas. Our data suggest that use of surgical approaches with complete margin assessment may improve local control and functional outcomes for patients with vulvar melanoma as they have for patients with other specialty site melanomas.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003734","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T13:00:13Z","timestamp":1677675613000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessing Rates of Positive Surgical Margins After Standard Excision of Vulvar Melanomas"],"prefix":"10.1097","volume":"49","author":[{"given":"Shayan","family":"Cheraghlou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole A.","family":"Doudican","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maressa C","family":"Criscito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Carucci","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ctrv.2018.12.005","article-title":"Vulvar malignant melanoma: pathogenesis, clinical behaviour and management: review of the literature","volume":"73","author":"Boer","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.10.015","article-title":"Epidemiology of genitourinary melanoma in the United States: 1992 through 2012","volume":"75","author":"Vyas","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2016.04.021","article-title":"Rare vulvar malignancies; incidence, treatment and survival in The Netherlands","volume":"142","author":"Pleunis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/1097-0142(19930301)71:5<1893::AID-CNCR2820710528>3.0.CO;2-7","article-title":"Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984","volume":"71","author":"Ragnarsson-Olding","year":"1993","journal-title":"Cancer"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ijgc-00009577-200109000-00004","article-title":"Vulvar melanoma at the M. D. Anderson cancer center: 25 years later","volume":"11","author":"Verschraegen","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20250731","article-title":"Prognostic factors of recurrence and survival in vulvar melanoma: subgroup analysis of the VULvar CANcer study","volume":"26","author":"Iacoponi","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2013.07.082","article-title":"A review of complications associated with the surgical treatment of vulvar cancer","volume":"131","author":"Wills","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","article-title":"Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm","volume":"318","author":"Veronesi","year":"1988","journal-title":"N Engl J Med"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archsurg.1991.01410280036004","article-title":"Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma","volume":"126","author":"Veronesi","year":"1991","journal-title":"Arch Surg"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(19)31132-8","article-title":"2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial","volume":"394","author":"Utj\u00e9s","year":"2019","journal-title":"Lancet"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa030681","article-title":"Excision margins in high-risk malignant melanoma","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.11272","article-title":"Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)","volume":"97","author":"Khayat","year":"2003","journal-title":"Cancer"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","article-title":"Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial","volume":"17","author":"Hayes","year":"2016","journal-title":"Lancet Oncol"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(11)61546-8","article-title":"2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial","volume":"378","author":"Gillgren","year":"2011","journal-title":"Lancet"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D","article-title":"Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm","volume":"89","author":"Cohn-Cedermark","year":"2000","journal-title":"Cancer"},{"key":"R17-20250731","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas","volume":"8","author":"Balch","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","article-title":"Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial","volume":"218","author":"Balch","year":"1993","journal-title":"Ann Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jaad.2018.11.008","article-title":"The rule of 10s versus the rule of 2s: high complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas","volume":"85","author":"Rzepecki","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2002.6848","article-title":"Mucosal melanoma of the female genital tract is a multifocal disorder","volume":"88","author":"Lotem","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1245\/s10434-014-4215-3","article-title":"Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases","volume":"22","author":"Seifried","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jogc.2018.07.011","article-title":"Melanoma of the vulva and vagina: surgical management and outcomes based on a clinicopathologic reviewof 68 cases","volume":"41","author":"Sinasac","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/DSS.0000000000000702","article-title":"Risk factors predicting positive margins at primary wide local excision of cutaneous melanoma","volume":"42","author":"Mangold","year":"2016","journal-title":"Dermatol Surg"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1245\/s10434-015-4942-0","article-title":"The association between excision margins and local recurrence in 11,290 thin (T1) primary cutaneous melanomas: a case-control study","volume":"23","author":"MacKenzie Ross","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1524-4725.2010.01618.x","article-title":"The invasive growth potential of residual melanoma and melanoma in situ","volume":"36","author":"DeBloom","year":"2010","journal-title":"Dermatol Surg"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","article-title":"Incident cases captured in the national cancer Database compared with those in U.S. Population based central cancer registries in 2012-2014","volume":"26","author":"Mallin","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamadermatol.2019.0267","article-title":"Evaluation of lymph node Ratio association with long-term patient survival after surgery for node-positive Merkel cell carcinoma","volume":"155","author":"Cheraghlou","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jso.25090","article-title":"Merkel cell carcinoma: clinical outcome and prognostic factors in 351 patients","volume":"117","author":"van Veenendaal","year":"2018","journal-title":"J Surg Oncol"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/lary.27444","article-title":"Adjuvant chemotherapy is associated with improved survival for late-stage salivary squamous cell carcinoma","volume":"129","author":"Cheraghlou","year":"2019","journal-title":"Laryngoscope"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2017.03.025","article-title":"Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas","volume":"77","author":"Miller","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.2004.06050.x","article-title":"Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma","volume":"151","author":"Moehrle","year":"2004","journal-title":"Br J Dermatol"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1245\/s10434-012-2543-8","article-title":"1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival?","volume":"20","author":"Hudson","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/SLA.0b013e31828421e1","article-title":"The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas","volume":"258","author":"Pasquali","year":"2013","journal-title":"Ann Surg"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/SLA.0000000000000792","article-title":"The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center","volume":"260","author":"Lamboo","year":"2014","journal-title":"Ann Surg"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1245\/s10434-015-4575-3","article-title":"Minimum safe pathologic excision margins for primary cutaneous melanomas (1-2 mm in thickness): analysis of 2131 patients treated at a single center","volume":"23","author":"Haydu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CMR.0b013e32835a310c","article-title":"Outcome following local recurrence or in-transit metastases in cutaneous melanoma","volume":"22","author":"Suoj\u00e4rvi","year":"2012","journal-title":"Melanoma Res"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2019.2346","article-title":"Evolution of excisional surgery practices for melanoma in the United States","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaad.2015.01.007","article-title":"Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment","volume":"72","author":"Etzkorn","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R41-20250731","first-page":"690","article-title":"Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience","volume":"32","author":"Bhardwaj","year":"2006","journal-title":"Dermatol Surg"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1524-4725.1998.tb04226.x","article-title":"Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow\u2010up study","volume":"24","author":"Cohen","year":"1998","journal-title":"Dermatol Surg"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/1097-0142(19940615)73:12<2964::AID-CNCR2820731213>3.0.CO;2-O","article-title":"Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections","volume":"73","author":"Cohen","year":"1994","journal-title":"Cancer"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/DSS.0000000000000248","article-title":"Five-year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort","volume":"41","author":"Hou","year":"2015","journal-title":"Dermatol Surg"},{"key":"R45-20250731","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamadermatol.2019.2890","article-title":"Comparison of survival after Mohs micrographic surgery vs wide margin excision for early-stage invasive melanoma","volume":"155","author":"Cheraghlou","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/DSS.0000000000002907","article-title":"Mohs for vulvar melanoma in situ","volume":"47","author":"Grewal","year":"2021","journal-title":"Dermatol Surg"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/DSS.0000000000001051","article-title":"Surgical treatment and outcomes of patients with extramammary Paget disease: a cohort study","volume":"43","author":"Kim","year":"2017","journal-title":"Dermatol Surg"},{"key":"R48-20250731","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/DSS.0000000000001355","article-title":"Intraoperative immunostaining for cytokeratin-7 during Mohs micrographic surgery demonstrates low local recurrence rates in extramammary Paget's disease","volume":"44","author":"Damavandy","year":"2018","journal-title":"Dermatol Surg"},{"key":"R49-20250731","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.urology.2022.04.036","article-title":"Interdisciplinary management of extramammary Paget's disease using Mohs micrographic surgery with frozen section cytokeratin-7 immunostains","volume":"166","author":"Bittar","year":"2022","journal-title":"Urology"},{"key":"R50-20250731","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamadermatol.2021.4812","article-title":"Sentinel lymph node biopsy positivity in patients with acral lentiginous and other subtypes of cutaneous melanoma","volume":"158","author":"Cheraghlou","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R51-20250731","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"R52-20250731","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa2005493","article-title":"Five-year analysis of adjuvant dabrafenib plus trametinib in stage III melanoma","volume":"383","author":"Dummer","year":"2020","journal-title":"N Engl J Med"},{"key":"R53-20250731","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1200\/JCO.20.02110","article-title":"Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: Updated results from the EORTC 1325-MG\/KEYNOTE-054 trial","volume":"38","author":"Eggermont","year":"2020","journal-title":"J Clin Oncol"},{"key":"R54-20250731","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB\u2013C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol"},{"key":"R55-20250731","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/cncr.33651","article-title":"Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery","volume":"127","author":"MacArthur","year":"2021","journal-title":"Cancer"},{"key":"R56-20250731","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaad.2022.08.021","article-title":"Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery","volume":"87","author":"Cheraghlou","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R57-20250731","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2018.10.026","article-title":"Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival","volume":"80","author":"Cheraghlou","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R58-20250731","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamadermatol.2021.0023","article-title":"Association of treatment facility characteristics with overall survival after Mohs micrographic surgery for T1a-T2a invasive melanoma","volume":"157","author":"Cheraghlou","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R59-20250731","article-title":"The impact of facility characteristics on Merkel cell carcinoma outcomes: a retrospective cohort study","author":"Cheraghlou","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R60-20250731","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/DSS.0000000000003268","article-title":"Systematic review of Technical variations for Mohs micrographic surgery for melanoma","volume":"47","author":"Krausz","year":"2021","journal-title":"Dermatol Surg"},{"key":"R61-20250731","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamadermatol.2021.0022","article-title":"Mohs micrographic surgery for melanoma\u2014do outcomes vary among treatment facilities?","volume":"157","author":"Miller","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R62-20250731","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/bjd.17510","article-title":"The illusion of conventional histological resection margin control","volume":"180","author":"Van Delft","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:02:58Z","timestamp":1753999378000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003734","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}